| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $979.1M | $879.2M | $817.3M |
| YoY Revenue Growth % | +11.4% | +7.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $238.4M | $136.0M | $188.8M |
| Operating Margin % | 24.4% | 15.5% | 23.1% |
| Net Income (GAAP) | $136.6M | $31.4M | $57.0M |
| EBITDA (Normalized) | $333.7M | $192.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $255.8M | $223.6M | $206.1M |
| Capital Expenditures (CapEx) | $119.1M | $70.9M | — |
| Free Cash Flow (FCF) | $136.7M | $152.8M | $206.1M |
| FCF Margin % | 14.0% | 17.4% | 25.2% |
| Return on Invested Capital (ROIC %) | 15.1% | 8.8% | — |
| Cash & Short-Term Equivalents | $65.3M | $77.6M | — |
| Total Debt (Short + Long Term) | $1.02B | $1.03B | — |
| Total Stockholders' Equity | $293.0M | $265.1M | — |